Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study.

Published on Apr 11, 2021in Multiple sclerosis and related disorders4.339
路 DOI :10.1016/J.MSARD.2021.102947
Mahdi Barzegar8
Estimated H-index: 8
(IUMS: Isfahan University of Medical Sciences),
Saeed Vaheb5
Estimated H-index: 5
(IUMS: Isfahan University of Medical Sciences)
+ 3 AuthorsVahid Shaygannejad25
Estimated H-index: 25
(IUMS: Isfahan University of Medical Sciences)
Sources
Abstract
Abstract The effect of coronavirus disease (COVID-19) on the risk of relapse in multiple sclerosis (MS) have been unknown. In this retrospective study of 41 relapsing-remitting MS patients, number of relapses in pre-defined at risk-period (ARP) was compared with the previous two years. During the previous two years, a total of 32 attacks was reported, which 5 (15.6%) were during the at-risk period. After adjusting for age and sex, there was an increased risk of attack during ARP compared to the previous two years (RR: 2.566, 95%CI: 1.075-6.124, P=0.034). Our preliminary study suggested that COVID-19 can trigger exacerbation of MS.
馃摉 Papers frequently viewed together
References10
Newest
#1Eric Song (Yale University)H-Index: 28
#2Ce Zhang (Yale University)H-Index: 3
Last. Yile Dai (Yale University)H-Index: 9
view all 39 authors...
Although COVID-19 is considered to be primarily a respiratory disease, SARS-CoV-2 affects multiple organ systems including the central nervous system (CNS). Yet, there is no consensus on the consequences of CNS infections. Here, we used three independent approaches to probe the capacity of SARS-CoV-2 to infect the brain. First, using human brain organoids, we observed clear evidence of infection with accompanying metabolic changes in infected and neighboring neurons. However, no evidence for typ...
Source
The novel coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a global challenge. Currently, there is some information on the consequences of COVID-19 infection in multiple sclerosis (MS) patients, as it is a newly discovered coronavirus, but its far-reaching effects on participation in neurodegenerative diseases seem to be significant. Recent cases reports showed that SARS-CoV-2 may be responsible for initiating the demye...
Source
#1Nicolas Vabret (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 11
#2Graham J. Britton (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 14
Last. Matthew D. Park (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 5
view all 88 authors...
Abstract The coronavirus disease 2019 (COVID-19) pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting an unprecedented effort from the scientific community to understand the biological underpinning of COVID19 pathophysiology. In this review, we summarize the current state of knowledge of innate and adaptive immune responses elicited by SARS-CoV-2 infection and the immunological pathways that likely contribute to dise...
Source
#1Omid Mirmosayyeb (IUMS: Isfahan University of Medical Sciences)H-Index: 12
#2Serge Brand (University of Basel)H-Index: 62
Last. Dena Sadeghi Bahmani (Kermanshah University of Medical Sciences)H-Index: 15
view all 7 authors...
Background: Compared to the adult onset of multiple sclerosis (AOMS), both early-onset (EOMS) and late-onset (LOMS) are much less frequent, but are often under- or misdiagnosed. The aims of the present study were: 1. To compare demographic and clinical features of individuals with EOMS, AOMS and LOMS, and 2. To identify predictors for disability progression from relapsing remitting MS (RRMS) to secondary progressive MS (SPMS). Method: Data were taken from the Isfahan Hakim MS database. Cases wer...
Source
#1Catharine I. Paules (Penn State Milton S. Hershey Medical Center)H-Index: 4
#2Hilary D. Marston (NIH: National Institutes of Health)H-Index: 17
Last. Anthony S. Fauci (NIH: National Institutes of Health)H-Index: 217
view all 3 authors...
Source
#1Alan J. Thompson (UCL: University College London)H-Index: 146
#2Brenda Banwell (Children's Hospital of Philadelphia)H-Index: 71
Last. Jeffrey A. Cohen (Cleveland Clinic)H-Index: 41
view all 30 authors...
Summary The 2010 McDonald criteria for the diagnosis of multiple sclerosis are widely used in research and clinical practice. Scientific advances in the past 7 years suggest that they might no longer provide the most up-to-date guidance for clinicians and researchers. The International Panel on Diagnosis of Multiple Sclerosis reviewed the 2010 McDonald criteria and recommended revisions. The 2017 McDonald criteria continue to apply primarily to patients experiencing a typical clinically isolated...
Source
#1John D. Kriesel (UofU: University of Utah)H-Index: 19
#2Andrea T. White (UofU: University of Utah)H-Index: 24
Last. Jack H. Petajan (UofU: University of Utah)H-Index: 28
view all 5 authors...
Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system, which often follows a relapsing/remitting (RR) course with discrete attacks. MS attacks have been associated with upper respiratory infections (URIs), but the specific viruses responsible have not been identified. We studied a cohort of 16 RRMS patients experiencing URI and followed them for clinically identifiable attacks. The viral causes of 21 separate URIs were investigated using culture and polymerase ...
Source
#1D Buljevac (EUR: Erasmus University Rotterdam)H-Index: 6
#2H Z FlachH-Index: 3
Last. Rogier Q. HintzenH-Index: 63
view all 9 authors...
One of the characteristics of multiple sclerosis is the unpredictable occurrence of exacerbations and remissions. These fluctuations in disease activity are related to alterations in (auto鈥)immune activity. Exacerbations lead to short鈥恡erm morbidity, but may also influence long鈥恡erm disability. This longitudinal study in 73 patients with relapsing鈥搑emitting multiple sclerosis assessed the contribution of systemic infections to the natural course of exacerbations. In addition, we analysed whether...
Source
#1S Edwards (University of Nottingham)H-Index: 1
#2ME ZvartauH-Index: 2
Last. L D BlumhardtH-Index: 1
view all 5 authors...
Background鈥擜lthough the risk of clinical attacks of multiple sclerosis seems to be significantly increased with viral upper respiratory tract infections (URTI), serological evidence for the reported association remains controversial. In addition, although MRI is six to 10 times more sensitive than clinical exacerbations in indexing disease activity, any possible association between URTI and MRI activity has yet to be investigated. Objectives鈥擳o examine the relation between URTI and disease activ...
Source
#1William A. Sibley (UA: University of Arizona)H-Index: 17
#2Colin R. Bamford (UA: University of Arizona)H-Index: 19
Last. Katherine Clark (UA: University of Arizona)H-Index: 3
view all 3 authors...
Abstract Over an 8 year period, 170 patients with multiple sclerosis (MS) and 134 healthy controls were assessed at monthly intervals in order to ascertain environmental factors which might be important in producing exacerbation or progression of the illness, and to compare the frequency of common viral infections in the two groups. During cumulative periods designated "at risk" (2 weeks before the onset of infection until 5 weeks afterwards) annual exacerbation rates were almost 3-fold greater ...
Source
Cited By4
Newest
(1) Background: To report and analyze the presence of residual symptoms after SARS-CoV-2 infection among Polish patients with multiple sclerosis (MS) treated with different disease-modifying therapies (DMTs). (2) Methods: The study included 426 individuals with MS treated with DMTs and confirmed SARS-CoV-2 infection from 12 Polish MS centers. The data were collected through to 31 May 2021. The information included demographics, specific MS characteristics, course of SARS-CoV-2 infection, and res...
Source
Abstract null null Introduction null : peripheral inflammation can exacerbate pre-existing lesions in the Central Nervous System (CNS) in the context of neurodegenerative diseases, including Multiple Sclerosis (MS). null null null Objective null : To analyze the clinical effect of COVID-19 infection, as a generator of peripheral inflammation, in a MS patients group. null null null Methods null : A retrospective analysis of 400 medical records of MS patients from a referral center was carried out...
Source
#1Berenice Anabel Silva (Fundaci贸n Instituto Leloir)H-Index: 2
#2Maria Isabel Farias (Fundaci贸n Instituto Leloir)H-Index: 5
Last. Carina Cintia Ferrari (Fundaci贸n Instituto Leloir)H-Index: 17
view all 7 authors...
Abstract null null Background null : Inflammation in the Central Nervous System (CNS) is associated with blood brain barrier (BBB) breakdown during the early stages of Multiple Sclerosis (MS), indicating a facilitated entry of waves of inflammatory cells from the circulation to the CNS. In the progressive forms of MS, as the lesion becomes chronic, the inflammation remains trapped within the CNS compartment forming the slow evolving lesion, characterized by low inflammation and microglia activat...
Source
#1Mahdi Barzegar (IUMS: Isfahan University of Medical Sciences)H-Index: 8
#2Omid Mirmosayyeb (IUMS: Isfahan University of Medical Sciences)H-Index: 12
Last. Nasrin Asgari (University of Southern Denmark)H-Index: 26
view all 8 authors...
Abstract null null Background null We conducted this systematic review and meta-analysis to assess the risk of coronavirus disease (COVID-19), clinical features and outcome among patients with Neuromyelitis Optica Spectrum Disorder (NMOSD). null null null Methods null We systematically searched PubMed, Scopus, Web of Science, and Embase from December 1, 2019, to July 2, 2021. The gray literature including the references of original studies, review studies, conference abstracts, and WHO COVID-19 ...
Source
#1Fereshteh Ghadiri (Tehran University of Medical Sciences)H-Index: 4
#2Mohammad Ali Sahraian (Tehran University of Medical Sciences)H-Index: 56
Last. Abdorreza Naser Moghadasi (Tehran University of Medical Sciences)H-Index: 14
view all 4 authors...
Abstract null null Background null At this time vaccination against SARS-CoV2 is a global priority. Cases with multiple sclerosis (MS) were among the first vaccinated populations in Iran. We evaluated the change in the frequency of COVID-19 after vaccination and the associated factors with severe COVID-19 infection before and after full vaccination. null null null Methods null A questionnaire was validated to investigate the basic characteristics (age, gender, education, body mass index, smoking...
Source
#1Sibel KarsidagH-Index: 13
#2Sevki SahinH-Index: 11
Last. Sude KendirliH-Index: 1
view all 0 authors...
Source
#1Mohsen Karami Fath (Kharazmi University)H-Index: 1
#2Abolfazl Jahangiri (BMSU: Baqiyatallah University of Medical Sciences)H-Index: 16
Last. Alireza Zakeri (SRTTU: Shahid Rajaee Teacher Training University)H-Index: 4
view all 12 authors...
Autoimmune diseases (ADs) could occur due to infectious diseases and vaccination programs. Since millions of people are expected to be infected with SARS-CoV-2 and vaccinated against it, autoimmune consequences seem inevitable. Therefore, we have investigated the whole proteome of the SARS-CoV-2 for its ability to trigger ADs. In this regard, the entire proteome of the SARS-CoV-2 was chopped into more than 48000 peptides. The produced peptides were searched against the entire human proteome to f...
Source
#1Carina C. Ferrari (Fundaci贸n Instituto Leloir)H-Index: 2
Resumen null null Las inflamaciones perifericas pueden exacerbar el dano preexistente en el sistema nervioso central en el contexto de enfermedades neurodegenerativas, tales como la enfermedad de Parkinson, la enfermedad de Alzheimer y la esclerosis multiple. Por ello, las inflamaciones sistemicas son consideradas un factor importante en el agravamiento y la evolucion de estas enfermedades neurodegenerativas. Las citocinas proinflamatorias perifericas pueden inducir la sintesis de citocinas dent...
Source
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.